Cargando…
Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies
As many patients with underlying psychiatric disorders may be infected with COVID-19, and COVID-19-affected subjects may frequently experience a new onset of psychiatric manifestations, concomitant use of psychotropic medications and COVID-19 therapies is expected to be highly likely and raises conc...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053373/ https://www.ncbi.nlm.nih.gov/pubmed/33866523 http://dx.doi.org/10.1007/s40263-021-00811-2 |